The C. elegans daf-2 mutants that live ten times longer than their peers aren't "super-worms." They’re more like biological statues. They’ve managed to survive by opting out of life—suppressing reproduction, slowing their movement, and essentially entering a state of metabolic surrender. We’re currently looking at two very different ways to approach human longevity, and I’m convinced we’re focusing on the wrong one.

The first approach, which I call the Entropy Dampener, suggests that aging is a fire we can only survive by cutting off the oxygen. By mimicking the daf-2 pathway—lowering IGF-1 and dampening mTOR—we aren’t building a more robust human. We're just slowing the rate of decay. That’s longevity via stasis.

The second approach is Kinetic Restoration. This theory argues that aging isn't caused by too much activity, but by the collapse of the homing signals that direct repair. My work on MUSE cells (Multilineage-differentiating Stress Enduring cells) suggests these endogenous repair crews are ready to go, but the systemic "GPS"—specifically the S1P gradient—becomes noisy or even inverts as we get older. The cells are there; the signal is gone.

If we keep following the "Worm Model," we risk creating a population of long-lived, low-vitality individuals who lack the metabolic permission to actually fix themselves. You can't renovate a house if you’ve turned off the electricity to save on the bill. I’m betting on signal integrity. The future of the field isn't in suppression; it’s in restoring the extracellular landscape so our own stem cells can find their way home. If we just focus on metabolic "quieting," we aren't curing aging—we're just perfecting a very long goodbye.

We need to move past the obsession with IGF-1 and start looking at the kinetic cost of repair. Does a longevity drug actually make an organism more resilient, or is it just harder to kill because it’s barely alive? Let’s stop funding biological taxidermy and start looking at the systemic handshake.